Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Gamme d'année
1.
Int Braz J Urol ; 41(4): 690-6, 2015.
Article de Anglais | MEDLINE | ID: mdl-26401861

RÉSUMÉ

PURPOSE: To evaluate the clinical value of computed tomography angiography (CTA) in reducing the risk of hemorrhage associated with mini-percutaneous nephrolithotomy (PCNL). MATERIALS AND METHODS: A total of 158 patients with renal or ureter stones who had undergone mini-percutaneous nephrolithotomy were retrospectively enrolled into this study from May of 2011 to April of 2014. Group 1 (65 patients) underwent computed tomography angiography, and Group 2 (93 patients) underwent non-contrast CT. The clinical characteristics of the patients and hemorrhagic complications were recorded. The hematologic complications (transfusion rate, and preoperative and postoperative hemoglobin values) were assessed. RESULTS: There were no statistically significant differences in age, body mass index(BMI), stone diameter, operative time, stone-free rate, and hospital stay between the 2 groups. In group 2, 1 patient (1.1%) developed a renal arteriovenous fistula and was treated with embolus therapy. In addition, Group 2 showed significantly drop in hemoglobin (3.6 g/dL vs. 2.4 g/dL, respectively; P < 0.001) and more transfusions (9.7% vs. 1.5%, respectively; P < 0.05) compared with Group 1. CONCLUSION: The study showed that patients who underwent computed tomography angiography prior to percutaneous nephrolithotomy had lower drop of hemoglobin and needed less transfusions. These findings may suggest that the use of computed tomography angiography may reduce the risk of bleeding during percutaneous nephrolithotomy.


Sujet(s)
Hémorragie/étiologie , Hémorragie/thérapie , Rein/vascularisation , Néphrostomie percutanée/effets indésirables , Tomoscintigraphie , Adolescent , Adulte , Sujet âgé , Angiographie/méthodes , Transfusion sanguine/statistiques et données numériques , Produits de contraste , Femelle , Hémoglobines/analyse , Hémoglobines/usage thérapeutique , Humains , Calculs rénaux/thérapie , Mâle , Adulte d'âge moyen , Durée opératoire , Hémorragie postopératoire , Études rétrospectives , Facteurs de risque , Jeune adulte
2.
Int. braz. j. urol ; 41(4): 690-696, July-Aug. 2015. tab, graf
Article de Anglais | LILACS | ID: lil-763057

RÉSUMÉ

ABSTRACTPurpose:To evaluate the clinical value of computed tomography angiography (CTA) in reducing the risk of hemorrhage associated with mini-percutaneous nephrolithotomy (PCNL).Materials and Methods:A total of 158 patients with renal or ureter stones who had undergone mini-percutaneous nephrolithotomy were retrospectively enrolled into this study from May of 2011 to April of 2014. Group 1 (65 patients) underwent computed tomography angiography, and Group 2 (93 patients) underwent non-contrast CT. The clinical characteristics of the patients and hemorrhagic complications were recorded. The hematologic complications (transfusion rate, and preoperative and postoperative hemoglobin values) were assessed.Results:There were no statistically significant differences in age, body mass index(BMI), stone diameter, operative time, stone-free rate, and hospital stay between the 2 groups. In group 2, 1 patient (1.1%) developed a renal arteriovenous fistula and was treated with embolus therapy. In addition, Group 2 showed significantly drop in hemoglobin (3.6 g/dL vs. 2.4 g/dL, respectively; P <0.001) and more transfusions (9.7% vs. 1.5%, respectively; P <0.05) compared with Group 1.Conclusion:The study showed that patients who underwent computed tomography angiography prior to percutaneous nephrolithotomy had lower drop of hemoglobin and needed less transfusions. These findings may suggest that the use of computed tomography angiography may reduce the risk of bleeding during percutaneous nephrolithotomy.


Sujet(s)
Adolescent , Adulte , Sujet âgé , Femelle , Humains , Mâle , Adulte d'âge moyen , Jeune adulte , Hémorragie/étiologie , Hémorragie/thérapie , Rein/vascularisation , Néphrostomie percutanée/effets indésirables , Tomoscintigraphie , Angiographie/méthodes , Transfusion sanguine/statistiques et données numériques , Produits de contraste , Hémoglobines/analyse , Hémoglobines/usage thérapeutique , Calculs rénaux/thérapie , Durée opératoire , Hémorragie postopératoire , Études rétrospectives , Facteurs de risque
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE